流感疫苗竟有可能导致急性播散性脑脊髓炎?

2017-10-10 张微微 戚晓昆 神经科少见病例

女性,55岁。上午接种流感疫苗,下午出现发热,最高体温38.5℃,前额及左颞部刀剜样痛,因持续4天之久入院治疗,患者为何在接种疫苗后出现上述症状?对此医生是如何诊断并治疗的?

女性,55岁。上午接种流感疫苗,下午出现发热,最高体温38.5℃,前额及左颞部刀剜样痛,因持续4天之久入院治疗,患者为何在接种疫苗后出现上述症状?对此医生是如何诊断并治疗的?

临床资料

患者,女性,55岁,退休医师,主因“发热、头痛4天”于2005年10月30日入院。患者于2005年10月26日上午接种流感疫苗,下午出现发热,最高体温38.5℃,前额及左颞部刀剜样痛,急诊查腰穿检查脑脊液压力210mmH2O,外观清亮,白细胞380×106/L,红细胞4×106/L。为明确诊断收入院。既往健康,近几年定期接种流感疫苗。个人史、家族史无特殊。

入院查体:体温:37.8℃,脉搏:72次/分,呼吸:16次/分,血压:130/80mmHg。内科查体未见其他异常。神经系统检查:意识清楚,语言清晰,智能粗测正常。双侧瞳孔直径3mm,对光反射灵敏。双侧鼻唇沟对称,伸舌居中,四肢肌力5级,无共济失调,无不自主运动。深浅感觉正常。四肢腱反射(++),左侧Babinski征(+),颈部略有抵抗,Kernig征(-)。入院后检查:血常规:WBC 11﹒7×109/L,粒细胞百分比74.4%;尿便常规、ESR正常;血清Cl:93.1mmol/L、CRP:7.48mg/L;HBsAg、抗HC、HIV及梅毒抗体(-);血谷丙转氨酶17U/L,总胆红素13.9μmol/L,直接胆红素5.3u,GLU 8﹒31mmol/L;BUN、Cr、TP正常;血PT 12﹒5秒、凝血酶原活动度94%、FIB 4g/L、APTT 24秒、INR 0﹒94;脑脊液检查:WBC 456×106/L、多核33%、淋巴细胞67%、RBC 4﹒0×106/L、糖3.03mmol/L、蛋白定量0.64g/L、氯化物118.4mmol/L。心电图及胸片未见异常。诊断:急性播散性脑脊髓炎。

诊疗经过:入院后给予甘露醇、阿昔洛韦、头孢曲松及地塞米松等治疗。11月1日查体向右粗大眼震,左侧鼻唇沟变浅,口角右偏,伸舌左偏,颈抵抗。左上肢肌力3级,下肢4-级,左Babinski征(+)。头颅MRI示右侧脑干、脑桥臂及小脑可见多个融合的T1WI低、T2WI不均匀高信号,周边呈低信号。T2 FLAIR见病灶周围高信号水肿影扩散至底节及右侧丘脑。增强扫描见薄壁不规则的环行强化,第四脑室受压改变,脑干肿胀。小脑扁桃体位于枕骨大孔以下。加用enoxaparin抗凝治疗。11月2日0:00左右醒后言语表达不能,左侧肢体全瘫,15分钟后缓解。同日上午查体发现右侧不完全性凝视麻痹,左上肢肌力3级,左下肢肌力2级,左侧肢体感觉减退,双侧腱反射(+++),左侧Babinski征(+),颈部略有抵抗。复查脑脊液:白细胞132×106/L、红细胞720×106/L、分叶粒细胞2%、淋巴98%;糖77mmol/L、蛋白0.50g/L、氯化物127.2mmol/L,脑脊液及血结明试验均为阴性;脑脊液TORCH筛查(-)。停阿昔洛韦、地塞米松,改甲泼尼龙1.0g/d冲击疗法。此后患者病情逐渐稳定,于11月18日症状体征减轻出院。随访左侧肢体肌力恢复到4级。



讨论

ADEM是一种广泛累及脑和脊髓白质的急性炎症性脱髓鞘疾病,常继发于感染免疫接种后,影像学上表现为非对称性、多灶性脑白质病变。ADEM是一种单时相病变(monophasic dis order)。病理表现为散布于脑和脊髓的小和中等静脉周围的脱髓鞘病变,病灶自0.1mm至数毫米不等,脱髓鞘区可见小神经胶质细胞,伴炎性反应,淋巴细胞形成血管袖套。严重时可继发脑疝。头颅MRI表现:T2WI及FLAIR序列脑脊髓片状高信号病变,增强扫描可有强化;灰质可以受累,如基底节、丘脑及脑干;通常无占位效应,但有瘤样病灶报告;胼胝体通常不受累(与MS鉴别);丘脑受累占40%(与MS鉴别)。治疗目前主要推荐大剂量甲泼尼龙及免疫球蛋白静脉点滴。

本患者特点:①中年女性;②疫苗接种后急性起病;脑实质弥漫性损害;③CSF‐MNC增多;蛋白轻度升高;④脑脊液及血结明试验均为阴性;脑脊液TORCH筛查(-);⑤头颅MRI示右侧脑干、桥臂及小脑可见多个融合的T1WI低、T2WI不均匀高信号,周边呈低信号;T2FLAIR见病灶周围高信号水肿影扩散至底节及右侧丘脑;增强扫描见薄壁不规则的环行强化,第四脑室受压改变,脑干肿胀。小脑扁桃体位于枕骨大孔以下;⑥甲泼尼龙1.0g/d冲击疗法治疗效果明显。符合ADEM的诊治标准。

点评

1﹒脑和(或)脊髓的急性炎性损害可由异常免疫反应引起。

2﹒异常免疫反应通常是在接种后1~2周发病者多;2~4周发病者较少;本例于接种后仅半天即发病,对于临床诊疗工作有参考意义。

3﹒临床病史询问应注意疫苗、药物、家禽、宠物、化学物品的接触史。

4﹒大冲量免疫球蛋白及肾上腺皮质激素冲击是有效的治疗方法。

随着卫生事业的进步,我国流感疫苗接种人群广泛,此病历提示临床医师应关注认识急性播散性脑脊髓炎。对于疫苗接种1个月内出现的发烧、精神症状、意识障碍、肢体瘫痪的患者要想到急性播散性脑脊髓炎;给予及时诊断、治疗,患者生命健康才得以保证。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
    2018-07-17 1e145228m78(暂无匿称)

    学习了.谢谢作者分享!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
    2018-09-22 xlysu
  5. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
    2017-10-12 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
    2017-10-11 yfjms

    学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
    2017-10-11 1e207054m17(暂无匿称)

    学习了.感谢.非常好的病历

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
    2017-10-10 changjiu

    学习了.谢谢

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1769418, encodeId=426b1e69418cf, content=<a href='/topic/show?id=3ca75e0059d' target=_blank style='color:#2F92EE;'>#播散性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=57005, encryptionId=3ca75e0059d, topicName=播散性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c90838047642, createdName=clmlylxy, createdTime=Mon Feb 19 04:30:00 CST 2018, time=2018-02-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=332131, encodeId=7c90332131b6, content=学习了.谢谢作者分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3xJXLtMtt5B40XXuPjn9xn1rBhrM6fHLkX1hI86ZoWoPJkgDkZuJNKkBfBHOcRd1fAdezg7JlHNOokohdAp3WkI/0, createdBy=32c81964262, createdName=1e145228m78(暂无匿称), createdTime=Tue Jul 17 06:41:55 CST 2018, time=2018-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2080308, encodeId=e4f820803086a, content=<a href='/topic/show?id=e2bf8504282' target=_blank style='color:#2F92EE;'>#脑脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=85042, encryptionId=e2bf8504282, topicName=脑脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fda6311, createdName=119337457, createdTime=Mon Jun 04 16:30:00 CST 2018, time=2018-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650426, encodeId=4ea31650426f8, content=<a href='/topic/show?id=b14384624a3' target=_blank style='color:#2F92EE;'>#脊髓炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84624, encryptionId=b14384624a3, topicName=脊髓炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=06db24008155, createdName=xlysu, createdTime=Sat Sep 22 08:30:00 CST 2018, time=2018-09-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=252159, encodeId=2f15252159b6, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu Oct 12 07:10:21 CST 2017, time=2017-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251993, encodeId=d3cd2519938f, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3da1990174, createdName=yfjms, createdTime=Wed Oct 11 16:49:43 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251853, encodeId=567f25185326, content=学习了.感谢.非常好的病历, beContent=null, objectType=article, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee2018203, createdName=1e207054m17(暂无匿称), createdTime=Wed Oct 11 05:45:32 CST 2017, time=2017-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251826, encodeId=a285251826a7, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zSn0GqHrsfLGSUSR8zwnWWLT4FMl5XH8S58HuZslVkLsAPbXDXaliagK7TOxQfmngKibG1yrDonepCLDkcxGk8hS/0, createdBy=b8282062892, createdName=changjiu, createdTime=Tue Oct 10 23:57:26 CST 2017, time=2017-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=251825, encodeId=215e25182550, content=学习了.谢谢, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 10 23:57:22 CST 2017, time=2017-10-10, status=1, ipAttribution=)]
    2017-10-10 惠映实验室

    学习了.谢谢

    0

相关资讯

同样是流感 为何广东报告死亡病例远低于香港

香港与内地采用的流感死亡病例统计口径不同,而流感病毒本身种类繁多,容易变异,可能会对流感疫苗的保护效力产生影响

死亡300余人,香港流感疫情破坏力为何如此之强?

截至8月7日,香港的夏季流感疫情已累计导致了327人死亡。 根据此前的报道,导致目前香港流感大爆发的主要原因是甲型流感,其中以H3N2毒株为主。而2016年甲型流感H3N2毒株出现的N121变异,也在本轮流行的病毒中检测出来。

Lancet infect dis:对于流感,奥司他韦、金刚烷胺和利巴韦林联合疗法竟不比奥司他韦单一疗法的效果好!

尽管已经建立了长期的疫苗接种计划和通过审批的抗病毒药物,但流感仍具有很大的社会经济和健康影响。临床前数据表明联合抗病毒疗法比单纯用奥司他韦治疗流感效果更好。

香港流感真的比SARS还厉害?专家:并非新病毒不要恐慌

传说中比SARS还厉害的流感到底是怎么回事?香港卫生署8月7日表示,自5月5日至8月6日,与流感相关的严重个案累积已达475宗,其中456宗为成人严重个案,19宗儿童严重个案。造成的死亡人数达327人,其中成人324例,儿童3例。卫生署在向传媒发布的新闻稿中指出,上述情况已经超越2003年严重急性呼吸道综合征(SARS)时期造成299人死亡的数字。不过,卫生署新闻及公共关系组负责人强调,不同疾病的

北京现流感传播可能性较低

近日媒体不断报道香港流感疫情,引起公众广泛关注。香港目前正值夏季流感流行季。香港卫生署表示,今年5月5日至8月6日期间,共有475宗严重流感个案,造成327人死亡。北京市疾控中心昨日下午发布流感监测数据显示,目前北京流感病毒活动处于较低水平,近期在北京社区内出现流感传播流行的可能性较低。

SCI Immu: 基因的差异导致不同个体对流感疫苗的免疫反应差异大

近日,耶鲁的科学家和他们的合作者发现了若干个与人体对流感疫苗的免疫反应有关的基因和基因簇。这项研究指出,利用个人的基因谱图预测个体对流感疫苗的免疫反应成为可能。